This document provides an overview of psychopharmacology for high-risk populations. It discusses the increased prevalence of mental health conditions like depression, PTSD, dementia, bipolar disorder, and schizophrenia in at-risk groups. The document then summarizes commonly prescribed medications for conditions such as depression, anxiety, mood stabilization, psychosis, and insomnia. It addresses primary neurotransmitter systems and side effects of these medications. Finally, it discusses considerations for HIV-psychotropic drug interactions and questions clinicians may encounter from clients regarding psychotropic medications.